Inventor

Mohamad Morsey

Inventor
Omaha, NE, US

Overview

23→
Patents
1999–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 23 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides28%
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C12NMicroorganisms or enzymes9%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms1%
PatentTitleYear
11,091,556Caninized human antibodies to human IL-4R alpha202110,927,172Caninized murine antibodies to human PD-1202110,858,437Antibodies to canine interleukin-4 receptor alpha202010,711,061Antibodies against canine PD-1202010,550,194PD-L1 antibodies binding canine PD-L1202010,106,607Caninized antibodies201810,023,636Caninized murine antibodies to human PD-120189,944,704Antibodies against canine PD-120189,409,954'Recombinant non-pathogenic marek\'s disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens'20168,932,604'Recombinant non-pathogenic marek\'s disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens'20158,791,242'Canine thymic stromal lymphopoietin protein and uses thereof to treat allergic symptoms'20148,784,829'Lawsonia intracellularis vaccines'20148,557,254'Lawsonia intracellularis bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel Lawsonia intracellularis serotype and hybridomas for producing the said antibodies'20138,273,356'Anti-IgE vaccines'20128,076,456'Fusion proteins comprising canine thymic stromal lymphopoietin protein and uses thereof'20117,897,151'Anti-IgE vaccines'20117,718,772'Canine thymic stromal lymphopoietin protein and uses thereof'20107,420,047'Non-anaphylactogenic IgE fusion proteins'20086,974,572'Non-anaphylactogenic IgE fusion proteins'20056,887,472'Anti-IgE vaccines'20056,759,393'Growth hormone and growth hormone releasing hormone compositions'20046,369,201'Myostatin multimers'20025,922,583'Methods for production of recombinant plasmids'1999

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1999Based in Saskatoon, CA· patent location history
2002–2012Based in Niantic, CT, US· patent location history
2004–2012Patents assigned to PFIZER (3)· patent assignee history
2005–2008Patents assigned to PFIZER PROD INC (3)· patent assignee history
2010–2021Based in Omaha, NE, US· patent location history
2011–2021Patents assigned to INTERVET INC (14)· patent assignee history
2011–2014Patents assigned to MORSEY MOHAMAD A (4)· patent assignee history
2011–2014Patents assigned to DE WAAL MALEFYT RENE (2)· patent assignee history
2013–2014Based in Elkhorn, NE, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
INTERVET INC142011–2021
MORSEY MOHAMAD Aself42011–2014
PFIZER32004–2012
PFIZER PROD INC32005–2008
DE WAAL MALEFYT RENE22011–2014
Locations
LocationPatentsSpan
Omaha, NE, US122010–2021
Niantic, CT, US72002–2012
Elkhorn, NE, US32013–2014
Saskatoon, CA11999